Lacunar infarcts are serious, though not in the dramatic way most people picture when they think of stroke. These small strokes, caused by blockage in the tiny arteries deep inside the brain, were long considered relatively benign because people tend to survive them and often recover well in the short term. But research over the past two decades has steadily dismantled that reassuring view. A few years out, the risk of death rises, mainly from cardiovascular causes, and the cumulative toll on thinking, mood, and independence can be substantial.
What a Lacunar Infarct Actually Is
A lacunar infarct is a small area of dead brain tissue, typically less than 15 millimeters across, caused by blockage of one of the tiny penetrating arteries that supply structures deep in the brain. The term “lacune” dates to the 1800s, but the underlying mechanism stayed murky until the 1960s, when the neurologist C. Miller Fisher studied brain autopsies and identified what he called “lipohyalinosis,” a process where the walls of these small vessels thicken, stiffen, and eventually choke off blood flow. Lipohyalinosis involves a buildup of hyaline material and fibrinoid deposits that narrow and eventually block the vessel from the inside out, typically in the setting of chronic high blood pressure.1PubMed. Lacunar stroke: mechanisms and therapeutic implications
A second major pathway involves atherosclerotic plaques in the larger “parent” arteries that sit at the mouth of these tiny branches, blocking their openings. Thickening of the small-vessel walls can also be driven by diabetes, amyloid deposits, or rare genetic conditions.2PubMed Central. Lacunar infarction and small vessel disease: pathology and pathophysiology Either way, the end result is the same: a small patch of brain tissue loses its blood supply and dies, leaving behind a tiny cavity, or “lacune.”
Symptoms and Classic Lacunar Syndromes
Because lacunar infarcts hit discrete deep-brain structures, they tend to produce predictable symptom patterns rather than the complex, mixed deficits seen with larger strokes. Clinicians have described five classic lacunar syndromes, though in practice the picture often overlaps. In one study of patients presenting with lacunar syndromes, pure motor stroke was the most common, followed by sensorimotor stroke, pure sensory stroke, atypical lacunar syndrome, ataxic hemiparesis, and dysarthria-clumsy hand syndrome.3PubMed Central. Clinical predictors of lacunar syndrome not due to lacunar infarction
The most frequent of these, pure motor stroke, typically presents as weakness on one side of the body without changes in sensation, vision, or language. It correlates strongly with a lacune located in the internal capsule, a narrow bundle of nerve fibers deep in the brain that serves as a highway for movement signals.4PubMed. The classic lacunar syndromes: clinical and neuroimaging correlates Pure sensory stroke involves numbness or tingling on one side, while sensorimotor stroke combines weakness with sensory loss. Ataxic hemiparesis produces clumsiness and weakness on the same side, and dysarthria-clumsy hand causes slurred speech with awkward hand movements.
One important caveat: having a lacunar syndrome does not guarantee the underlying cause is actually a lacunar infarct. Research on diagnostic accuracy found that the positive predictive value of a lacunar syndrome for a true lacunar infarct was about 65%, rising to roughly 75% for pure motor syndrome specifically.5PubMed. Diagnostic accuracy and risk factors of the different lacunar syndromes That means roughly one in three patients presenting with lacunar-looking symptoms turns out to have a different type of stroke or a non-stroke cause altogether. Brain imaging, usually MRI, is essential to confirm the diagnosis.
Risk Factors and How They Compare to Other Strokes
High blood pressure is the dominant risk factor for lacunar infarcts, which makes sense given that the underlying vessel damage is driven by chronic pressure on tiny arteries. But the conventional wisdom that lacunar strokes have a dramatically different risk-factor profile from other stroke types is probably overstated. A systematic review found that when studies used classification methods that were not themselves based on risk factors, the excess of hypertension in lacunar versus non-lacunar stroke patients was only modest, and diabetes showed no difference at all.6PubMed Central. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts
What does seem to distinguish lacunar infarcts is what they are less associated with. Patients with lacunar strokes are significantly less likely to have atrial fibrillation, significant narrowing of the carotid artery, or heart disease compared with non-lacunar stroke patients.7PubMed. Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? This supports the idea that lacunar infarcts arise from intrinsic disease of the small vessels themselves, rather than from clots traveling from the heart or large arteries, even though they share many of the same background risk factors like smoking, high cholesterol, and sedentary lifestyle.
Silent Lacunar Infarcts
Perhaps the most unsettling aspect of lacunar infarcts is that many of them produce no obvious symptoms at all. These “silent” infarcts are typically discovered incidentally on brain MRI done for other reasons, and they are far more common than people realize. In one large community-based study, roughly 28% of older participants showed evidence of silent infarcts on MRI. Those with silent infarcts had nearly double the rate of future symptomatic stroke compared to those without, and the risk climbed further when multiple silent infarcts were present.8PubMed. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study
A large Chinese study tracking over half a million adults found something even more striking: the prognosis of silent lacunar infarcts was comparable to symptomatic ones. The five-year risks of recurrent stroke were similar (about 38% for silent versus 43% for symptomatic), as were rates of death.9The Lancet Regional Health – Western Pacific. Natural history of silent lacunar infarction: 10-year follow-up of a community-based prospective study of 0.5 million Chinese adults The implication is clear: just because a lacunar infarct did not cause noticeable symptoms does not mean it is harmless. The same small-vessel disease that produced it is actively ongoing, and the risk of future events is real.
Short-Term Prognosis and Recovery
In the immediate aftermath, lacunar strokes do look comparatively mild. Most patients survive, and initial recovery tends to be fast. At one year after a lacunar infarct, about 12% of patients were dependent in daily activities, though that figure climbed to roughly 24% at three years, mostly due to recurrent strokes. The strongest predictor of poor long-term function was having moderate or severe weakness a month after the stroke, followed by the presence of white matter disease on brain MRI.10PubMed. Functional outcome in patients with lacunar infarction
One encouraging finding is that people with lacunar strokes appear to have a better shot at late improvement than those with other stroke types. A population-based study found that lacunar stroke patients were significantly more likely to continue improving between three months and one year, even though their three-month outcomes were similar to other stroke survivors.11PubMed. Late functional improvement after lacunar stroke: a population-based study This probably reflects the brain’s ability to reroute function around small, deep lesions more easily than around large cortical ones.
The Long Game Is Less Reassuring
The early optimism fades when you look further out. A hospital-based study found a five-year survival rate of about 86% after a first lacunar stroke, but the five-year rate of surviving free of a recurrent stroke was only 63%.12PubMed. Long-term prognosis of first-ever lacunar strokes. A hospital-based study. In other words, more than a third of patients had another stroke within five years. And while lacunar stroke patients fare better than cortical stroke patients on long-term survival, the gap does not erase the real hazards: a nine-year follow-up study confirmed that cortical stroke patients were significantly more likely to die, but lacunar stroke patients still faced meaningful rates of death, with age, male sex, and the burden of white matter disease all increasing risk.13PubMed Central. Functional, Cognitive, Physical, and Vascular Outcomes 9 Years After Lacunar and Mild Cortical Ischemic Stroke
A review in Lancet Neurology put it bluntly: lacunar infarcts have commonly been regarded as benign vascular lesions with a favorable long-term prognosis, but recent studies show this is only true early in the disease course, with risk of death increasing over the following years, predominantly from cardiovascular causes.14PubMed. Long-term prognosis after lacunar infarction The small-vessel disease behind lacunar infarcts is a systemic process, and the heart and kidneys are often affected by the same microvascular damage.
Effects on Thinking and Mood
Even when physical recovery goes well, lacunar infarcts can quietly erode cognitive function. The pattern of impairment is characteristic of subcortical damage: slowed processing speed, reduced hand dexterity, and difficulty with executive functions like planning and organizing.15PubMed Central. Cognitive impairment in lacunar strokes: The Secondary Prevention of Small Subcortical Strokes (SPS3) Trial Memory often remains relatively intact early on, which can make the deficits harder to notice since neither the patient nor their family may recognize slowed thinking as a stroke consequence.
The mood effects are equally insidious. Research has found an association between the volume of lacunar infarcts in white matter and symptoms of depression, apathy, loss of pleasure, and fatigue, supporting the role of subcortical vascular disease in late-life psychiatric conditions.16PubMed Central. The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia This “vascular depression” can look identical to ordinary late-life depression but may respond differently to treatment. Clinicians who recognize the vascular contribution may approach medication choices and expectations differently than they would with garden-variety depression.
Treatment in the Acute Phase
When someone arrives at the hospital with a suspected lacunar stroke, the initial treatment follows the same general emergency protocol as other ischemic strokes. The key question has been whether intravenous clot-dissolving medication (thrombolysis) works as well for these small-vessel strokes as it does for strokes caused by large-artery blockages.
Data from the WAKE-UP trial showed that thrombolysis with alteplase was associated with higher odds of a favorable outcome in lacunar stroke patients, with no difference in treatment benefit compared to non-lacunar stroke types. About 59% of lacunar stroke patients treated with alteplase had a favorable outcome versus 46% on placebo, though the difference did not reach statistical significance given the small subgroup size.17PubMed Central. Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial A secondary analysis of the AcT trial found that safety and functional outcomes after thrombolysis were actually better in patients with lacunar infarcts compared to the overall trial population.18PubMed Central. Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial
One treatment that does not apply to lacunar strokes is mechanical thrombectomy, the catheter-based procedure that has transformed outcomes for strokes caused by large-vessel blockages. Because lacunar infarcts involve tiny arteries too small to reach with a catheter, thrombectomy simply is not an option. This has created a growing concern in stroke medicine: as thrombectomy has dramatically improved outcomes for large-vessel strokes, lacunar stroke patients have not shared in those gains, potentially shifting the relative prognosis.
Preventing a Second Stroke
After the acute phase, the focus shifts to preventing recurrence, and this is where treatment decisions get complicated. The SPS3 trial, the largest randomized trial focused specifically on lacunar stroke, tested two strategies: dual antiplatelet therapy (aspirin plus clopidogrel) versus aspirin alone, and a lower blood pressure target (under 130 mmHg systolic) versus a standard target (130 to 149 mmHg).
The antiplatelet results were sobering. Dual therapy did not significantly reduce recurrent stroke compared to aspirin alone after an average follow-up of 3.4 years. Recurrent stroke occurred at a rate of about 2.5% per year with dual therapy versus 2.7% per year with aspirin alone. But the risk of major bleeding nearly doubled with the combination.19PubMed Central. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke For most patients with lacunar stroke, long-term dual antiplatelet therapy does not appear to be worth the bleeding risk. A more recent meta-analysis did find that dual antiplatelet therapy was superior to single therapy in preventing recurrent ischemic stroke, but also confirmed significantly more bleeding, so the trade-off remains contentious and context-dependent.20PubMed Central. Clinical Efficacy and Safety of Dual Versus Single Antiplatelet Therapy in Lacunar Stroke
The blood pressure arm of SPS3 was more encouraging. Although the lower target did not reach statistical significance for reducing all strokes, it did significantly cut the rate of brain hemorrhage. The trial authors concluded that a systolic blood pressure target below 130 mmHg is likely beneficial for patients with recent lacunar stroke.21PubMed Central. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial Given that the small-vessel damage behind lacunar strokes is largely driven by chronic hypertension, aggressive blood pressure control remains the cornerstone of secondary prevention.
Imaging Markers That Signal Trouble Ahead
Brain MRI does more than just confirm a lacunar infarct. It can reveal a constellation of other changes that signal the broader burden of small-vessel disease and help predict who is at greatest risk going forward. Enlarged perivascular spaces, particularly in the basal ganglia region, are independently associated with the lacunar stroke subtype and with the severity of white matter damage.22PubMed. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease White matter hyperintensities, those bright spots scattered through the brain’s white matter on MRI, are a marker of chronic small-vessel damage and predict worse outcomes in terms of both survival and cognitive decline after lacunar stroke.
The connection extends beyond the brain. Chronic kidney disease has been linked to enlarged perivascular spaces and total small-vessel disease burden in patients with lacunar stroke, reinforcing the idea that this is a systemic microvascular problem rather than a purely brain-based one.23PubMed. Chronic Kidney Disease in Patients With Lacunar Stroke: Association With Enlarged Perivascular Spaces and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease If you have had a lacunar infarct and your MRI shows heavy white matter disease or numerous enlarged perivascular spaces, your long-term risk profile is meaningfully worse than someone whose MRI is relatively clean aside from the lacune itself.
Obstructive Sleep Apnea and Small-Vessel Disease
An underappreciated contributor to cerebral small-vessel disease is obstructive sleep apnea. A systematic review and meta-analysis found that patients with sleep apnea had significantly higher odds of both white matter hyperintensities and silent lacunar infarcts compared with people without the condition.24PubMed. Impact of obstructive sleep apnea on silent cerebral small vessel disease: a systematic review and meta-analysis The connection appears to be driven partly by repeated oxygen drops during sleep: oxygen desaturation measures were independently associated with higher overall small-vessel disease burden in stroke patients.25Frontiers in Neurology. Associations of sleep apnea risk and oxygen desaturation indices with cerebral small vessel disease burden in patients with stroke
Moderate-to-severe sleep apnea in particular has been linked to higher grades of white matter damage and enlarged perivascular spaces.26PubMed. Moderate-to-severe obstructive sleep apnea is associated with cerebral small vessel disease For someone who has had a lacunar infarct, screening for and treating sleep apnea may be a genuinely useful intervention that often goes overlooked in the rush to manage blood pressure and start antiplatelet medication. The evidence is not yet from randomized trials proving that CPAP prevents further infarcts, but the association is strong enough that most stroke specialists consider sleep apnea screening reasonable in this population.
When the Cause Is Genetic
Most lacunar infarcts are caused by the familiar combination of hypertension, diabetes, and aging. But in younger patients, especially those under 55 who develop lacunar strokes without obvious risk factors, genetic conditions deserve a closer look. The most well-known is CADASIL, caused by mutations in the NOTCH3 gene that alter the structure of small brain arteries.27PubMed Central. Association of NOTCH3 Variant Position With Stroke Onset and Other Clinical Features Among Patients With CADASIL CADASIL typically presents with recurrent lacunar strokes, migraine with aura, progressive cognitive decline, and mood disturbances, often beginning in the 30s or 40s.
A study screening younger patients with MRI-confirmed lacunar stroke found pathogenic NOTCH3 mutations in a small but meaningful number of cases. All five identified CADASIL patients had confluent white matter disease on MRI but few of the classic non-stroke features of the condition, which means the diagnosis can easily be missed if genetic testing is not pursued.28PLOS ONE. Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke Fabry disease is another genetic condition that can cause lacunar strokes through damage to small vessels, and it is treatable with enzyme replacement therapy, making its detection particularly important.
Genetic testing will not change anything for the typical 70-year-old with high blood pressure who has a lacunar stroke. But for younger patients, identifying one of these conditions alters surveillance, family screening, and in some cases available treatment.